CTOs on the Move

Albrite

www.albrite.com

 
Albrite is a Tarpon Springs, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.albrite.com
  • 709 Bayou Ave
    Tarpon Springs, FL USA 34689
  • Phone: 727.781.5111

Executives

Name Title Contact Details

Similar Companies

Lightforce Orthodontics

The World`s First, and Only, Fully-Customized 3D Printed Bracket System

Alick's Home Medical Equipment

Alick's Home Medical Equipment is a South Bend, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oasis Medical

Oasis Medical is a Glendora, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lasergen

Lasergen is an emerging biotechnology company focused on commercializing novel technologies for DNA sequencing. Our expertise in nucleotide chemistry and next-generation sequencing has led to a number of key discoveries resulting in both game-changing sequencing chemistry (Lightning Terminators™) and a more accurate sequencing platform. While focusing on the development of current cutting-edge technology, our continued drive for innovation and extensive sequencing knowledge allows us to rapidly evolve and keep pace with fast-changing advances in the sequencing industry.

iSpecimen

Headquartered in Lexington, MA, iSpecimen offers an online marketplace for the purchase of human biospecimens, providing researchers with the specimens they need from the patients they want. The iSpecimen Marketplace connects healthcare organizations that have access to patients and specimens with the scientists who need them for their research and development projects. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. And ultimately, healthcare advances for all.